Diabetes
From the Journals
Intermittent fasting can lead to type 2 diabetes remission
Intermittent fasting could be a paradigm shift in type 2 diabetes management, allowing patients to stop taking glucose-lowering medication.
From the Journals
DELIVER subanalysis ‘seals deal’ for dapagliflozin in HF
An analysis of the large global DELIVER trial found that dapagliflozin improved outcomes and symptoms across a wide range of heart failure...
Guidelines
ADA issues 2023 ‘Standards of Care’ for diabetes: Focus on tight BP, lipids
The new 2023 American Diabetes Association Standards of Care address management of diabetes and its complications, as well as social determinants...
From the Journals
Low-carb, high-fat, calorie-unrestricted diet improves type 2 diabetes
The benefits of the diet were seen regardless of a person’s calorie intake.
Conference Coverage
Cognitive behavioral therapy app lowers A1c in type 2 diabetes
People with type 2 diabetes who used a smartphone app for cognitive behavioral therapy had a significant drop in their A1c levels.
From the Journals
Given the choice, T2D patients find their own best meds
People with type 2 diabetes who tried agents from three different classes of glucose-lowering drugs usually found one they liked most. It was...
News
FDA okays Dexcom G7 continuous glucose monitoring system
The new version has several advantages over the G6, including smaller size, shorter warm-up time, and a 12-hour grace period before expiring.
From the Journals
Cold water immersion can have benefits
Immersion in cold water has a major impact on the body.
Guidelines
Guideline stresses new strategies for hypoglycemia management
The latest guideline from The Endocrine Society updates recommendations to reflect new treatment options for hypoglycemia prevention and treatment...
From the Journals
Diabetes decision tool yields ‘modest’ benefit in low-resource clinics
Another positive of this tool is that it could curtail physician burnout, authors of new research say.
From the Journals
Dapagliflozin reduces hospitalizations in patients with CKD
A new analysis adds to a growing body of evidence supporting a range of positive benefits from dapagliflozin.